ConductScience.org, home
VTCN1: V-set domain containing T cell activation inhibitor 1
API referenceFor AI assistants

Gene · 79679

Papers2,409

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

61 to 80 of 2,409

Download this page as JSON
TitleJournalYearPMIDFound bySource
Temporal dynamics in cancer immunotherapy: the interplay between circadian rhythms, tumor microenvironment, and immune checkpoint blockade.J Natl Cancer Cent202641738042PubTator, text miningPubMed
Denosumab Plus Immune Checkpoint Inhibitors in Bone Metastases From Solid Tumors.Cancer Control202641733374PubTator, text miningPubMed
Diversity and function of tumor-associated macrophages in brain metastases: mechanisms and therapeutic prospects.Front Immunol202641727473PubTator, text miningPubMed
The tumor microenvironment in hematologic malignancies: immune evasion, metabolic reprogramming, and therapeutic resistance.Blood Sci202641726040PubTator, text miningPubMed
Single-cell epigenetic profiling reveals a tumor-intrinsic interferon response program in ccRCC tied to poor prognosis and BAP1 loss.Sci Adv202641719400PubTator, text miningPubMed
Three Cases of Resection of Alpha-Fetoprotein-Positive High-Grade Fetal Adenocarcinoma of the Lung From a Single Institution.Cureus202641717591PubTator, text miningPubMed
Targeted biologics for TNBC: Advances in nanobodies, antibodies, peptides, and aptamers.Mol Ther Oncol202641716468PubTator, text miningPubMed
Ubiquitin-Specific Protease 10: A New Target in Tumor Immune Escape.Cancer Control202641711750PubTator, text miningPubMed
Antibody-Drug Conjugates in Gynecologic Oncology: Advances, Challenges, and Future Directions.BioDrugs202641703397PubTator, text miningPubMed
Harnessing PDX and PDX 2.0: the next-generation paradigm for precision oncology and translational breakthroughs.Mol Cancer202641699647PubTator, text miningPubMed
Bispecific Antibodies in Breast Cancer Immunotherapy: Mechanisms, Advances, and Translational Challenges.Target Oncol202641637006PubTator, text miningPubMed
Intratumoral PD-1high CD8+ T cells correlate with AFP levels in HCC patients: a brief report.Cell Oncol (Dordr)202641632329PubTator, text miningPubMed
Evaluating a data-driven approach to biomarker discovery for tumor-targeted imaging in epithelial ovarian cancer.Biomarkers202641586462PubTator, text miningPubMed
Major clinical advances in gynecologic cancer in 2025: from de-escalation strategies to precision therapies beyond BRCA.J Gynecol Oncol202641575332PubTator, text miningPubMed
c-JUN enhances CRISPR knockin anti-B7-H3 CAR T cell function in small cell lung cancer and thoracic SMARCA4-deficient undifferentiated tumors.Cell Rep Med202641564857PubTator, text miningPubMed
Bispecific and multispecific T-cell engagers: advancing the future of immunotherapy.Antib Ther202641561192PubTator, text miningPubMed
Role of tumor‑infiltrating lymphocytes and miR‑155 in breast cancer: Insights into carcinogenesis and their potential as prognostic biomarkers (Review).Oncol Rep202641543151PubTator, text miningPubMed
Fully human anti-B7-H4 antibody induces lysosome-dependent ferroptosis to reverse primary resistance to PD-1 blockade.J Immunother Cancer202641526167PubTator, text miningPubMed
A novel TM4SF4-targeting therapeutic antibody candidate with antitumor activity by blocking IGF1R and CD44 signaling and downregulating PD-L1 and B7-H4.Theranostics202641356204PubTator, text miningPubMed
State of the art and future directions in the treatment of metastatic adenoid cystic carcinoma.Curr Opin Oncol202641222550PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Previous pageNext page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/79679/papers?page=4

API referenceFor AI assistants